
Scientists have successfully used a patient's own immune cells to target unique cancer mutations. This breakthrough offers a blueprint for treating common cancers.

Scientists have successfully used a patient's own immune cells to target unique cancer mutations. This breakthrough offers a blueprint for treating common cancers.